Domenico Regoli
Affiliations: | Université de Sherbrooke, Sherbrooke, Québec, Canada |
Area:
Cell Biology, ImmunologyGoogle:
"Domenico Regoli"
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Regoli D, Gobeil F. (2016) Kinins and peptide receptors. Biological Chemistry. 397: 297-304 |
Savard M, Côté J, Tremblay L, et al. (2015) Safety and pharmacokinetics of a kinin B1 receptor peptide agonist produced with different counter-ions. Biological Chemistry |
Regoli D, Gobeil F. (2015) Critical insights into the beneficial and protective actions of the kallikrein-kinin system. Vascular Pharmacology. 64: 1-10 |
Gobeil F, Sirois P, Regoli D. (2014) Preclinical pharmacology, metabolic stability, pharmacokinetics and toxicology of the peptidic kinin B1 receptor antagonist R-954. Peptides. 52: 82-9 |
Rodi D, Buzzi A, Barbieri M, et al. (2013) Bradykinin B₂ receptors increase hippocampal excitability and susceptibility to seizures in mice. Neuroscience. 248: 392-402 |
Rizzi A, Campi B, Camarda V, et al. (2012) In vitro and in vivo pharmacological characterization of the novel NK₁ receptor selective antagonist Netupitant. Peptides. 37: 86-97 |
Regoli D, Plante GE, Gobeil F. (2012) Impact of kinins in the treatment of cardiovascular diseases. Pharmacology & Therapeutics. 135: 94-111 |
Calo' G, Rizzi A, Cifani C, et al. (2011) UFP-112 a potent and long-lasting agonist selective for the Nociceptin/Orphanin FQ receptor. Cns Neuroscience & Therapeutics. 17: 178-98 |
Guerrini R, Salvadori S, Rizzi A, et al. (2010) Neurobiology, pharmacology, and medicinal chemistry of neuropeptide S and its receptor. Medicinal Research Reviews. 30: 751-77 |
Bossi F, Fischetti F, Regoli D, et al. (2009) Novel pathogenic mechanism and therapeutic approaches to angioedema associated with C1 inhibitor deficiency. The Journal of Allergy and Clinical Immunology. 124: 1303-10.e4 |